Cargando…
Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243756/ https://www.ncbi.nlm.nih.gov/pubmed/36821849 http://dx.doi.org/10.1093/oncolo/oyad048 |
| _version_ | 1785054490662010880 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10243756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102437562023-06-07 Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies Oncologist Correction Oxford University Press 2023-02-23 /pmc/articles/PMC10243756/ /pubmed/36821849 http://dx.doi.org/10.1093/oncolo/oyad048 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. |
| spellingShingle | Correction Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title | Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title_full | Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title_fullStr | Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title_full_unstemmed | Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title_short | Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies |
| title_sort | correction to: managing ibrutinib-intolerant patients with b-cell malignancies |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243756/ https://www.ncbi.nlm.nih.gov/pubmed/36821849 http://dx.doi.org/10.1093/oncolo/oyad048 |